Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
177
about 2.1 years
18+
1 site in LA
Why this study is shown
What this study is about
Researchers are testing whether human placental membrane products, used with standard care, are more effective than standard care alone for nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). The trial will last 763 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.AM/Double - DFU
- 2.AM/Double - VLU
- 3.AM/Single - DFU
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Adverse Events, Change in pain in target ulcer, Determine improvement in quality of life
Dermatology, Endocrinology, Cardiology / Heart